Table 1. Comparison of dyspnea, physical function, ADL and QOL over time in the each group.
Diary group | Control group | ||||||
---|---|---|---|---|---|---|---|
Baseline (n=15) |
3 months (n=12) |
6 months (n=8) |
Baseline (n=18) |
3 months (n=11) |
6 months (n=7) |
||
Age (years) | 73.0 ± 6.6 | 71.9 ± 5.8 | 73.4 ± 6.0 | 71.8 ± 7.5 | 72.6 ± 6.9 | 72.1 ± 6.6 | |
Diagnosis (COPD/IPF) | 12/3 | 9/3 | 6/2 | 14/4 | 8/3 | 5/2 | |
Gender (Male/Female) | 11/4 | 9/3 | 6/2 | 13/5 | 8/3 | 6/1 | |
Height (cm) | 158.3 ± 10.3 | 158.3 ± 9.5 | 156.4 ± 11.2 | 161.2 ± 9.6 | 164.0 ± 10.7 | 166.5 ± 6.8 | |
Weight (kg) | 59.5 ± 10.3 | 58.7 ± 8.2 | 55.5 ± 7.2* | 57.8 ± 8.6 | 60.5 ± 7.3 | 62.4 ± 6.7 | |
Body Mass Index (kg/m²) | 23.6 ± 2.5 | 23.4 ± 2.0 | 22.6 ± 1.1* | 22.3 ± 3.2 | 22.6 ± 2.6 | 22.7 ± 3.5 | |
mMRC | 1.9 ± 0.7 | 1.4 ± 1.0* | 0.6 ± 0.5* | 1.3 ± 1.0 | 1.5 ± 0.8 | 0.9 ± 0.7 | |
Knee extension strength (WBI) | 0.601 ± 0.136 | 0.638 ± 0.107 | 0.701 ± 0.152 | 0.536 ± 0.204 | 0.530 ± 0.167 | 0.548 ± 0.268 | |
6MWD (m) | 451.1 ± 83.1 | 503.5 ± 79.4** | 510.8 ± 88.3 | 448.1 ± 118.3 | 460.7 ± 137.1 | 469.4 ± 177.4 | |
CS-30 (time) | 14.3 ± 3.9 | 18.4 ± 3.4* | 19.5 ± 4.4* | 16.1 ± 4.8 | 15.4 ± 7.0 | 15.9 ± 8.6 | |
NRADL | 96.8 ± 3.8 | 97.4 ± 5.4 | 98.4 ± 3.8 | 95.5 ± 8.6 | 96.9 ± 6.2 | 98.3 ± 1.9 | |
SGRQ | 28.2 ± 18.5 | 23.0 ± 20.4 | 14.8 ± 17.0 | 21.2 ± 19.8 | 23.5 ± 20.4 | 20.0 ± 22.1 | |
CAT | 10.9 ± 7.1 | 10.3 ± 9.5 | 6.0 ± 7.8 | 10.0 ± 8.6 | 9.6 ± 7.3 | 8.4 ± 10.3 |
Mean ± standard deviation is presented. *p<0.05 and **p<0.01 compared to baseline in each groups. IPF: idiopathic pulmonary fibrosis; mMRC: modified Medical Research Council dyspnea scale; WBI: weight bearing index; 6MWD: 6-minute walking distance; CS-30: 30-second chair stand test; NRADL: The Nagasaki University Respiratory ADL questionnaire; SGRQ: The St. George’s Respiratory Questionnaire; CAT: The COPD Assessment Test